How many days does it take for Vyvanse (lisdexamfetamine) to be cleared from the body in a typical adult?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 24, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Vyvanse Clearance Timeline

Vyvanse (lisdexamfetamine) is essentially cleared from your system within 2-3 days after the last dose, with the active metabolite d-amphetamine being 95% eliminated within 48 hours. 1, 2

Pharmacokinetic Profile

Prodrug (Lisdexamfetamine) Elimination

  • Lisdexamfetamine itself is rapidly eliminated with a half-life of less than 1 hour 1, 3
  • Plasma levels of the intact prodrug become undetectable by 6-8 hours after administration 1, 3
  • The prodrug is converted to d-amphetamine in red blood cells through enzymatic hydrolysis, not in the liver 1

Active Metabolite (d-Amphetamine) Elimination

  • d-Amphetamine has a half-life of 10-11.3 hours in adults 1, 4
  • 95% of d-amphetamine is eliminated within 48 hours after the final dose 2
  • Steady-state d-amphetamine levels are reached by day 5 of daily dosing 2
  • Peak plasma concentrations occur at approximately 4.4 hours after ingestion 1, 4

Complete System Clearance

For practical purposes, Vyvanse is cleared from the body in 2-3 days:

  • After 48 hours: 95% of the active d-amphetamine is eliminated 2
  • After 72 hours (3 days): Essentially complete elimination, given the 10-11 hour half-life means approximately 6-7 half-lives have passed 1, 4
  • By 5 days: No detectable accumulation occurs with repeated dosing, confirming complete clearance between this timeframe 2

Urinary Excretion Pattern

  • 96% of the administered dose is recovered in urine over 120 hours (5 days) 1, 3
  • 42% appears as amphetamine metabolites 1
  • 25% as hippuric acid 1
  • Only 2% as intact lisdexamfetamine 1
  • Less than 0.3% is excreted in feces 3

Clinical Caveats

Factors that may prolong clearance:

  • Renal impairment: Since 85-96% is renally excreted, kidney dysfunction will significantly delay elimination 1, 3
  • Urinary pH: Acidic urine increases amphetamine excretion, while alkaline urine prolongs it (though this is not explicitly stated in the Vyvanse literature, it applies to all amphetamines) 1
  • Age: Elderly patients may have slightly prolonged elimination due to reduced renal function 1

The 2-3 day clearance timeline assumes normal renal function and applies to both single doses and chronic daily use. 1, 2

Related Questions

What is the equivalent dosage of dexamphetamine (Dextroamphetamine) when converting from Lisdexamphetamine (Vyvanse)?
Does Vyvanse (lisdexamfetamine) need to be taken on an empty stomach?
What is the equivalent dose of Vyvanse (lisdexamfetamine) for Adderall (amphetamine/dextroamphetamine) 20mg twice daily (BID)?
Can a short-acting medication, such as Ritalin (methylphenidate) or Adderall (amphetamine and dextroamphetamine), be added as needed to a patient's regimen of Vyvanse (lisdexamfetamine) 40mg for days when only 5 hours of coverage is required due to a variable work schedule and difficulty sleeping when taking Vyvanse later than usual?
What is the expected timeframe for the maximum effect of Vyvanse (lisdexamfetamine) to occur in a patient who starts feeling its effects within 45 minutes?
Should hydroxychloroquine (Plaquenil) 200 mg daily be started in a 39‑year‑old patient with pronounced Raynaud’s phenomenon, abnormal nail‑fold capillary microscopy, normal inflammatory markers and creatine kinase, low‑titer Th/To antibodies (possible PM‑Scl‑75), negative antinuclear antibody, anti‑double‑stranded DNA, Ku and antiphospholipid antibodies, and no visceral organ involvement?
What are the recommended guidelines for administering intravenous fluids to a patient with congestive heart failure who is also volume‑depleted?
Why is a calcium‑channel blocker (CCB) not automatically indicated in a 39‑year‑old patient with pronounced Raynaud’s phenomenon, abnormal nail‑fold capillaroscopy, low‑titer anti‑Th/To antibodies and no visceral involvement?
Should albendazole be administered only at night?
How should a urinary tract infection caused by Pseudomonas aeruginosa in a female patient be interpreted and managed?
What long‑term antiplatelet therapy is recommended for a patient five years after percutaneous coronary intervention who has a moderate risk of gastrointestinal bleeding?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.